AbbVie strikes deal on Chinese cancer treatment drug that may be worth $2.9 billion

·

·

AbbVie strikes deal on Chinese cancer treatment drug that may be worth $2.9 billion

PHARMACEUTICALS. AbbVie strikes deal on cancer treatment drug. Support our journalism. Subscribe today. U.S. drugmaker AbbVie and Chinese drug developer I-Mab agreed to collaborate on a cancer treatment in a deal that could be worth more than …
See Original Article

Small pin with a big message; passenger receives BLM pin from airline after incident on flight

An encounter between two passengers on a recent Delta Air Lines flight from the Twin Cities to Washington, D.C., is gaining national attention on social media, but it’s not for the reasons you might think. Demetria Poe applauds how Delta handled an incident …
See Original Article

Smith & Wesson, citing strong demand for guns, announces record quarterly sales

SPRINGFIELD — Smith & Wesson Brands Inc. said this week that its firearms business had revenue of $230 million in its most recent quarter, a figure that represents shipments of more than 584,000 guns. Both of those numbers are new records, the …
See Original Article

Making Routine Medicine Safe, Rust Belt Town's Political Loyalties Divide, American Food Banks …

Bloomberg Businessweek Editor Joel Weber and Bloomberg News Senior Trade Reporter Shawn Donnan profile the political divide in Ambridge, PA
See Original Article

Hemp-CBD dietary supplement bill introduced in the House

Rep. Kurt Schrader (D-OR) and Rep. Morgan Griffith (R-VA) have introduced the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 to allow hemp and hemp derived CBD to be legally marketed in dietary supplements.
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.